Home/Healthcare/Diagnostics/Neurorehabilitation Market

Neurorehabilitation Market - Strategic Insights and Forecasts (2026-2031)

Market Analysis, Forecasts and Opportunities By Product (Neuro-Robotic Systems, Wearable Devices, Brain Computer Interfaces, Non-Invasive Stimulators, Neuronal Prosthetics, Others), By Application (Stroke, Traumatic Brain Injury (TBI), Spinal Cord Injury (SCI), Parkinson's Disease, Cerebral Palsy, Others), By End-user (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings), and Geography

Market Size in 2025
USD 1.857 billion
Market Size in 2031
USD 3.679 billion
CAGR
12.07%
Study Period
2020-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

Neurorehabilitation Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $1.86B in 2025 to $3.68B by 2031 at a CAGR of 12.07%.
Neurorehabilitation Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $1.86B in 2025 to $3.68B by 2031 at a CAGR of 12.07%.

Highlights:

  1. 1
    Growing prevalence of neurological disorders driving market demand
    The increasing incidence of stroke, traumatic brain injury, spinal cord injury, Parkinson’s disease, and multiple sclerosis is significantly boosting demand for neurorehabilitation therapies and technologies aimed at improving functional recovery and patient quality of life.
  2. 2
    Technological advancements transforming rehabilitation practices
    Innovations such as robotic exoskeletons, brain-computer interfaces, virtual reality systems, wearable devices, and neurostimulation technologies are revolutionizing neurorehabilitation by enabling personalized, precise, and more effective treatment approaches.
  3. 3
    Rising emphasis on functional recovery and patient independence
    Healthcare providers are increasingly focusing on restoring mobility, motor skills, and independence in patients with neurological impairments, which is accelerating the adoption of comprehensive neurorehabilitation programs across hospitals, clinics, rehabilitation centers, and home care settings.
  4. 4
    North America leading the global market with strong infrastructure and investments
    North America is expected to hold a substantial market share due to advanced healthcare infrastructure, supportive reimbursement policies, high neurological disease prevalence, and strong research and development investments by major companies such as Medtronic plc and Abbott Laboratories.

Neurorehabilitation alludes to different treatments, mediations, and hardware that are planned to advance utilitarian recuperation, reestablish versatility, and work on personal satisfaction in patients experiencing neurological illnesses or mishaps. Stroke, spinal rope injury, Parkinson's infection, different sclerosis, and different issues might be among them.

The Neurorehabilitation market size is growing quickly, attributable to an expansion in the recurrence of neurological illnesses, mechanical enhancements, and steady government endeavors. As the discipline is created, there is huge potential for extra advances in neurorehabilitation methodology and hardware, eventually prompting improved results and a better life for those with neurological impedances.

Neurorehabilitation Market Growth Drivers:

  • Increasing Prevalence of Neurological Disorders:

As the rate of neurological ailments like stroke, horrendous mind injury, and numerous cases of sclerosis rises, so does the interest in neurorehabilitation medicines. Market expansion is driven by the growing demand for effective rehabilitation solutions from this expanding patient population.

  • Technological Advancements in Rehabilitation Devices:

Advanced rehabilitation technologies like robotic exoskeletons, brain-computer interfaces, and virtual reality systems have revolutionized neurorehabilitation. These state-of-the-art contraptions convey precise and customized treatment activities, tempting medical services experts and impelling business sector development.

  • Growing Focus on Functional Recovery and Quality of Life:

There is a developing accentuation on upgrading practical recuperation and working on personal satisfaction for those with neurological infections. By providing comprehensive rehabilitation programs, neurorehabilitation plays a crucial role in achieving these goals, leading to increased demand and market expansion. 

Neurorehabilitation Market Key Players:

  • Medtronic PLC: Medtronic is a worldwide clinical innovation supplier that gives an exhaustive scope of neurorehabilitation gear and treatments. Neurostimulation frameworks, implantable gadgets, and other new answers for the treatment of neurological ailments are important for their portfolio.

  • DIH Medical Group: DIH’s subsidiary Hocoma AG manufactures sensor-based neurorehabilitation systems. Automated treatment frameworks, augmented reality stages, and sensor-helped restoration gear for upper and lower appendage recovery are among their contributions.

  • Saebo Inc.: Saebo is a company that specializes in upper limb rehabilitation equipment and solutions. They provide several goods, including functional orthoses and robotic treatment systems, to help people with neurological problems improve their hand and arm function.

Neurorehabilitation Market Geographical Outlook:

  • North America is anticipated to hold a considerable neurorehabilitation market share.

North America is projected to account for a significant market share which is attributable to various factors. Firstly, the region contains sophisticated healthcare infrastructure, such as specialized rehabilitation centers and research organizations, which encourage the use of neurorehabilitation technology. Also, neurological illnesses are common in North America, increasing the requirement for appropriate rehabilitation methods. Furthermore, favorable reimbursement regulations and government activities promoting neurorehabilitation contribute to the region's neurorehabilitation market share. Furthermore, the presence of significant companies in North America, as well as continuing expenditures in research and development operations, reinforce its market position in the Neurorehabilitation market.

Neurorehabilitation Market Key Developments:

  • In February 2023, Lupin Limited launched the first-of-its-kind computer and robotic-assisted Neurorehabilitation Center “Atharv Ability” in Mumbai. The center would provide rehabilitation programs for patients suffering from spinal cord & brain injury and other neurological conditions such as Parkinson's, multiple sclerosis, and cerebral palsy.

Neurorehabilitation Market Scope: 

Report Metric Details
Total Market Size in 2025 USD 1.857 billion
Total Market Size in 2031 USD 3.679 billion
Forecast Unit USD Billion
Growth Rate 12.07%
Study Period 2020 to 2031
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2031
Segmentation Product, Application, End-user, Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies
  • Medtronic plc
  • Abbott Laboratories
  • Bionik Laboratories Corp.
  • Ekso Bionics Holdings Inc.
  • DIH Medical Group

Market Segmentation

By Product

Neuro-Robotic System
Wearable Devices
Brain Computer Interface
Non-Invasive Stimulators
Neuronal Prosthetics
Others

By Application

Stroke
Traumatic Brain Injury (TBI)
Spinal Cord Injury (SCI)
Parkinson's Disease
Cerebral Palsy
Others

By End-user

Hospitals
Clinics
Rehabilitation Centers
Home Care Settings

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION MARKET BY PRODUCT

5.1. Introduction

5.2. Neuro-Robotic System

5.3. Wearable Devices

5.4. Brain Computer Interface

5.5. Non-Invasive Stimulators

5.6. Neuronal Prosthetics

5.7. Others  

6. NEUROREHABILITATION MARKET BY APPLICATION

6.1. Introduction

6.2. Stroke

6.3. Traumatic Brain Injury (TBI)

6.4. Spinal Cord Injury (SCI)

6.5. Parkinson's Disease

6.6. Cerebral Palsy

6.7. Others   

7. NEUROREHABILITATION MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Rehabilitation Centers

7.5. Home Care Settings    

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Medtronic plc

10.2. Abbott Laboratories

10.3. Bionik Laboratories Corp.

10.4. Ekso Bionics Holdings, Inc.

10.5. DIH Medical Group

10.6. ReWalk Robotics

10.7. BioXtreme Ltd.

10.8. Kinova

10.9. Saebo Inc.   

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061615682
PublishedJan 2026
Pages151
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The neurorehabilitation market is expected to reach a total market size of USD 3.679 billion by 2031.

Neurorehabilitation Market is valued at USD 1.857 billion in 2025.

The neurorehabilitation market is expected to grow at a CAGR of 12.07% during the forecast period.

The Neurorehabilitation market growth is expanding steadily as the frequency of neurological illnesses rises and the demand for effective rehabilitation methods rises.

The North American region is anticipated to hold a significant share of the neurorehabilitation market.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon